Nazim Benzerdjeb
8PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 25, 2026
Insights From Mutational and Transcriptomic Profiles in Epithelial-myoepithelial Carcinoma.Ziyad Alsugair, Françoise Descotes, Anne Champagnac
|May 15, 2024
Uncovering the WWTR1::NCOA2 Gene fusion in low-grade myoepithelial-rich neoplasm with HMGA2 expression: A case report.Ziyad Alsugair, Daniel Pissaloux, Françoise Descotes
|May 16, 2022
5-hmC loss is another useful tool in addition to BAP1 and MTAP immunostains to distinguish diffuse malignant peritoneal mesothelioma from reactive mesothelial hyperplasia in peritoneal cytology cell-blocks and biopsies.Ziyad Alsugair, Vahan Kepenekian, Tanguy Fenouil
|Jun 25, 2021
Combined grade and nuclear grade are prognosis predictors of epithelioid malignant peritoneal mesothelioma: a multi-institutional retrospective study.Nazim Benzerdjeb, Peggy Dartigues, Vahan Kepenekian
|Apr 15, 2021
Tertiary lymphoid structures in epithelioid malignant peritoneal mesothelioma are associated with neoadjuvant chemotherapy, but not with prognosis.Nazim Benzerdjeb, Peggy Dartigues, Vahan Kepenekian
Pageof 2
